TISSUE PROTEOME ANALYSIS OF HORMONE RECEPTOR-POSITIVE BREAST CANCER.

被引：0
|
作者：
Yoneten, K. Karaosmanoglu [1 ]
Gunes, A. [2 ]
Kasap, M. [3 ]
Utkan, N. Z. [4 ]
Akpinar, G. [3 ]
Gurel, B. [5 ]
Guler, S. A. [4 ]
机构：
[1] Kocaeli Univ, Fac Technol, Dept Biomed Engn, Kocaeli, Turkey
[2] Derince Training & Res Hosp, Dept Gen Surg, Kocaeli, Turkey
[3] Kocaeli Univ, Fac Med, Dept Med Biol, Kocaeli, Turkey
[4] Kocaeli Univ, Fac Med, Dept Gen Surg, Kocaeli, Turkey
[5] Kocaeli Univ, Fac Med, Dept Med Pathol, Kocaeli, Turkey
来源：
MOLECULAR BIOLOGY OF THE CELL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P2204
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Proteomic prediction in hormone receptor-positive breast cancer.
    Hennessy, B. T.
    Gonzalez-Angulo, A. M.
    Lu, Y.
    Tibes, R.
    Siwak, D.
    Sahin, A.
    Kau, S.
    Hortobagyi, G. N.
    Valero, V.
    Mills, G. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 13S - 13S
  • [2] Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.
    Malik, Faizan
    Ali, Naveed
    Jafri, Syed Imran Mustafa
    Sundermeyer, Mark L.
    Seidman, Michael Jeffrey
    Fidler, Christian Joseph
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Serum collagen fragments and outcomes in hormone receptor-positive metastatic breast cancer.
    Leitzel, Kim
    Ali, Suhail M.
    Vasekar, Monali K.
    Nagabhairu, Vinod
    Marks, Eric
    Ali, Ayesha
    Krecko, Laura
    Willumsen, Nicholas
    Leeming, Diana Julie
    Karsdal, Morten Asser
    Lipton, Allan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] miRNA signatures of prognostic significance in single hormone receptor-positive breast cancer.
    Senkus-Konefka, Elzbieta
    Popeda, Marta
    Kunc, Michal
    Bienkowski, Michal
    Braun, Marcin
    Lacko, Aleksandra
    Radecka, Barbara
    Pikiel, Joanna
    Litwiniuk, Maria
    Pogoda, Katarzyna
    Izycka-Swieszewska, Ewa
    Zaczek, Anna Joanna
    Biernat, Wojciech
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Androgen Receptor in Hormone Receptor-Positive Breast Cancer
    Khan, Ashfia Fatima
    Karami, Samaneh
    Peidl, Anthony S.
    Waiters, Kacie D.
    Babajide, Mariam Funmi
    Bawa-Khalfe, Tasneem
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [6] Disparities in Hormone Receptor-Positive Breast Cancer
    Ogayo, Esther R.
    Mittendorf, Elizabeth A.
    Kantor, Olga
    [J]. CURRENT BREAST CANCER REPORTS, 2024, 16 (01) : 106 - 115
  • [7] Palbociclib for hormone receptor-positive breast cancer
    Harding, Emilia
    [J]. LANCET ONCOLOGY, 2015, 16 (07): : E318 - E318
  • [8] Disparities in Hormone Receptor-Positive Breast Cancer
    Esther R. Ogayo
    Elizabeth A. Mittendorf
    Olga Kantor
    [J]. Current Breast Cancer Reports, 2024, 16 : 106 - 115
  • [9] Progesterone receptor signaling in estrogen receptor-positive breast cancer.
    Young, Amy
    Guan, Jane
    Daemen, Anneleen
    Friedman, Lori
    Lin, Kui
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 81 - 81
  • [10] Outcome of neoadjuvant-treated young patients with hormone receptor-positive breast cancer.
    Mayte Villarreal-Garza, Cynthia
    Arce-Salinas, Claudia
    Lasa, Federico
    Reynoso, Nancy
    Antonio Matus, Juan
    Lara-Medina, Fernando
    Bargallo-Rocha, Enrique
    Flores Diaz, Diana Fabiola
    Shaw, Robin J.
    Alvarado-Miranda, Alberto
    Jaime Castaneda, Noel
    Alejandra Martinez-Cannon, Bertha
    Mohar, Alejandro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345